Extracorporeal blood oxygenation and ozonation (EBOO) in man. preliminary report

Di Paolo N, Bocci V, Garosi G, et al. International Journal of Artificial Organs, 2000.

View the abstract on PubMed

Study type
Case report
People studied
Not reported
Population
Early human recipients of EBOO, including patients with atherosclerotic vasculopathy
Published
2000, International Journal of Artificial Organs
Identifiers
PMID 10741810
Group
Studies of EBO2 / EBOO specifically

What the authors reported

In the first human use of the EBOO apparatus, an author who self-tested the device noted disappearance of lipomas after six treatments; the device was then used in a patient with Madelung disease and several patients with atherosclerotic vasculopathy, with reported clinical benefit and no observed side effects.

What limits this result

Uncontrolled preliminary case series performed by the device's own inventors, including self-experimentation; no blinding, randomization, or precisely reported total sample size.

Research on the procedure itself. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.

Where we cite this study

All studies we track